CA
NZ
UK
AU
IND
US
Director Fred E. Cohen filed a Form 4 with the SEC on November 4, 2026, disclosing a disposition of 25,000 shares of CareDx, Inc. common stock on November 3, 2026, via a gift transaction.
Director Susan H. Snow filed a Form 4 with the SEC on November 4, 2026, disclosing two acquisitions of NeoVolta Inc. common stock issued in connection with Board of Director services, held indirectly through The Susan Hegarty Snow Trust.
Derek J. Maetzold, President and Chief Executive Officer of Castle Biosciences, Inc. (NASDAQ:CSTL), filed a Form 4 on November 4, 2026, disclosing sales of common stock executed on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Director Chandler G. Weeks of NeoVolta Inc. filed a Form 4 on November 4, 2026, disclosing two acquisitions of common stock issued in connection with Board of Director services, with transactions dated November 10, 2025, and October 19, 2026.
NeoVolta Inc. director John A. Hass filed a Form 4 on November 4, 2026, disclosing two acquisitions of common stock issued in connection with Board of Director services, with transactions dated November 10, 2025 and October 19, 2026.
Cheche Group Inc. CEO and Director Zhang Lei filed a Form 4 on November 4, 2026, disclosing the acquisition of 250,000 Class B ordinary shares granted directly by the company on November 3, 2026, under its 2026 Equity Incentive Plan.
Director Mark P. Frissora filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 33,334 shares of Series D Convertible Preferred Stock in BioAdaptives, Inc. (OTC:BDPT) on November 2, 2026, issued as compensation for board services.
Michal Nath Puri, Chief Human Resources Officer of NovoCure Ltd, filed a Form 4 on November 3, 2026, disclosing a sale of 660 ordinary shares on November 2, 2026, to cover tax withholding obligations arising from the vesting of Restricted Stock Units.
Patrick Tomlinson, President/CEO of Marsh People & Investments at Marsh & McLennan Companies, Inc., filed a Form 4 on November 4, 2026, disclosing transactions in common stock dated November 2, 2026.
Director Carmen Bauza of Destination XL Group, Inc. filed a statement of changes in beneficial ownership on November 4, 2026, disclosing an acquisition of common stock on November 2, 2026, issued as her elected form of quarterly retainer compensation.
Please wait processing your request...